Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview Survey.

Huang WT, Erickson SR, Hansen RA, Wu CH.

Medicine (Baltimore). 2016 Jun;95(25):e3909. doi: 10.1097/MD.0000000000003909.

2.
3.

Nonmedical information seeking amid conflicting health information: negative and positive effects on prostate cancer screening.

Gibson L, Tan AS, Freres D, Lewis N, Martinez L, Hornik RC.

Health Commun. 2016;31(4):417-24. doi: 10.1080/10410236.2014.963786.

PMID:
26362829
4.

Determinants of participation in prostate cancer screening: a simple analytical framework to account for healthy-user bias.

Tabuchi T, Nakayama T, Fukushima W, Matsunaga I, Ohfuji S, Kondo K, Kawano E, Fukuhara H, Ito Y, Oshima A.

Cancer Sci. 2015 Jan;106(1):108-14. doi: 10.1111/cas.12561.

5.

Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer.

Mathews M, Ryan D, Gadag V, West R.

Curr Oncol. 2014 Jun;21(3):e441-8. doi: 10.3747/co.21.1843.

6.

National evidence on the use of shared decision making in prostate-specific antigen screening.

Han PK, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL, Klabunde CN.

Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.

7.

Utilization of prostate cancer screening according to dietary patterns and other demographic variables. The adventist health study-2.

Ibrayev Y, Oda K, Fraser GE, Knutsen SF.

J Cancer. 2013 Jun 28;4(5):416-26. doi: 10.7150/jca.6442.

8.
9.

Remaining Life Expectancy Measurement and PSA Screening of Older Men.

Kotwal AA, Mohile SG, Dale W.

J Geriatr Oncol. 2012 Jul 1;3(3):196-204.

10.

The utilization of oncology web-based resources in Spanish-speaking Internet users.

Simone CB 2nd, Hampshire MK, Vachani C, Metz JM.

Am J Clin Oncol. 2012 Dec;35(6):520-6. doi: 10.1097/COC.0b013e31821d4906.

11.

Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population.

Hosain GM, Sanderson M, Du XL, Chan W, Strom SS.

Cent Eur J Public Health. 2011 Mar;19(1):30-4.

12.

Trends in prostate-specific antigen test use, 2000-2005.

Ross LE, Taylor YJ, Howard DL.

Public Health Rep. 2011 Mar-Apr;126(2):228-39.

13.

Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey.

Hoffman RM, Lewis CL, Pignone MP, Couper MP, Barry MJ, Elmore JG, Levin CA, Van Hoewyk J, Zikmund-Fisher BJ.

Med Decis Making. 2010 Sep-Oct;30(5 Suppl):53S-64S. doi: 10.1177/0272989X10378701.

14.

The role of tobacco-specific media exposure, knowledge, and smoking status on selected attitudes toward tobacco control.

Blake KD, Viswanath K, Blendon RJ, Vallone D.

Nicotine Tob Res. 2010 Feb;12(2):117-26. doi: 10.1093/ntr/ntp184.

15.

Low-income fathers' access to health insurance.

Corman H, Noonan K, Carroll A, Reichman NE.

J Health Care Poor Underserved. 2009 Feb;20(1):152-64. doi: 10.1353/hpu.0.0120.

16.

Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001.

Kinsey T, Jemal A, Liff J, Ward E, Thun M.

J Natl Cancer Inst. 2008 Jul 16;100(14):1003-12. doi: 10.1093/jnci/djn207.

17.

Delivery of cancer screening: how important is the preventive health examination?

Fenton JJ, Cai Y, Weiss NS, Elmore JG, Pardee RE, Reid RJ, Baldwin LM.

Arch Intern Med. 2007 Mar 26;167(6):580-5.

18.

The effect of physician-patient discussions on the likelihood of prostate-specific antigen testing.

Ross LE, Richardson LC, Berkowitz Z.

J Natl Med Assoc. 2006 Nov;98(11):1823-9.

Items per page

Supplemental Content

Support Center